ロード中...
Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)
PURPOSE: In men with localized prostate cancer, dose-escalated conformal radiotherapy (CFRT) improves efficacy outcomes at the cost of increased toxicity. We present a detailed analysis to provide further information about the incidence and prevalence of late gastrointestinal side effects. METHODS A...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Science Inc
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2937212/ https://ncbi.nlm.nih.gov/pubmed/19836155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2009.05.052 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|